0 results for 'Robbins Geller Rudman Dowd LLP'
Yacht Broker Says It 'Has Done Nothing Wrong.' Asks Miami Court to Dismiss the Case
"there is no scheme, no contract, no combination, nor a conspiracy," said one defendant of the antitrust litigation.
These South Florida Yacht Brokers May Need Representation as Antitrust Class Surfaces
"Because this is such a big case, ... we expect other suits to follow," said Ricardo Martinez-Cid, of Miami's Podhurst Oreck.
'10's of Billions at Stake': Insulin Case Gets OK with Miami Attorney in Lead
"This is a case that goes back 20 years, so the damages are substantial," said the Miami attorney representing the MDL
Celebrating Outstanding Achievements: The 2023 Elite Trial Lawyers
The National Law Journal is proud to recognize professional excellence in plaintiffs litigation as well as lifetime achievements and diversity and inclusion initiatives. For the first time, the Elite Trial Lawyers awards also included The Plaintiffs Firm of the Year.
Judge Enters Final Approval of $25M Drug Antitrust Class Action Settlement, $7M in Attorney Fees
U.S. District Judge Karen Marston granted the plaintiff's motion for approval Wednesday, which also included an award of $7 million in attorney fees and $2.3 million in costs.
Law Journal Press | Digital Book
State Antitrust Law
Authors: William T. Lifland
View this Book
View more book results for the query "Robbins Geller Rudman Dowd LLP"
Plaintiffs Bar Partner Promotions Highlight Rising Caseload, Commitment to Firm Culture
Plaintiffs firms are off to a dynamic start into 2023 with diverse partner classes and a strong commitment to antitrust, MDL and health care litigation.
2023 to Be a Busy Year for the Plaintiffs Bar—Here Is What You Need to Know
Plaintiffs bar leaders are mostly optimistic about business and litigation trends in 2023, but are also seeing some bumps on the road ahead.
Silicon Legal: Another Antitrust Advocate Aims for High Office, Plans Big Tech Takedown
"Dismantling their power will be no small task," Fordham University law professor Zephyr Teachout wrote in her book last year. "We can break them up, and work toward banning their poisonous business model."
EpiPen Class Action Heads to Trial on Curtailed Antitrust Claim
U.S. District Judge Daniel Crabtree in June tossed claims brought under the U.S. Racketeer Influenced and Corrupt Organizations Act and some of the antitrust allegations against Mylan Pharmaceuticals, which sold the EpiPen, a pen-like device that treats anaphylaxis, a potentially fatal condition caused by food allergies and insect bites. Trial is set for Sept. 7.
Does Impeding Public Discourse Violate Antitrust Rules? Plaintiffs Say Yes in Big Tech Suits
"[T]he question is going to be: Have newspapers lost advertising revenue not simply because of Google and Facebook and any practices they have adopted, but because we now have different technologies that we like and use?" says one antitrust lawyer.TRENDING STORIES
More from ALM
- Legal Speak at Legalweek 2024: Priori CEO and Co-Founder Basha Rubin; Shook, Hardy & Bacon Partner Patrick Oot 1 minute read
- Legal Speak at Legalweek 2024: Relativity's Director of AI Transformation and Law Firm Strategy Cristin Traylor; Zeem Solutions GC and Chief Privacy Officer John Meyer 1 minute read
- Legal Speak at Legalweek 2024: Cimplifi GC Marla Crawford and Everlaw VP of Marketing Joshua Schnoll 1 minute read
Resources
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now
Practical Guidance Journal: Protecting Work Product in a Generative AI World
Brought to you by LexisNexis®
Download Now
Countdown to Compliance: SEC Private Fund Reforms
Brought to you by Ontra
Download Now